中医辨证疗法应用于慢性阻塞性涎腺炎治疗的临床研究  

Study of Integrated Traditional Chinese and Western Medicine in the Treatment of Chronic Obstructive Salary Gland Inflammation

在线阅读下载全文

作  者:顾明明 

机构地区:[1]山东省宁阳县第一人民医院,山东宁阳271400

出  处:《中国医学创新》2012年第27期3-5,共3页Medical Innovation of China

摘  要:目的:研究中西医结合治疗慢性阻塞性涎腺炎的临床效果。方法:选择笔者所在医院2004-2010年间收治的52例慢性阻塞性涎腺炎患者为研究对象,将所有患者随机分为西医组与中西医结合组各26例,西医组采用基础保守治疗,中西医组在上述基础上采用中医辨证治疗,两组治疗30d后比较成功率、复发率、全身局部炎症情况、唾液总流率、B超腺体检查结果。结果:52例患者中腮腺结石15例,腮腺分支导管阻塞者2例;下颌下腺结石34例,下颌下腺分支导管阻塞1例,其治疗结果为西医组中首次治疗成功者21例(80.8%),复发者3例(11.5%),1例行腺体摘除;中西医结合组首次治疗成功24例(92.3%),1例治疗效果不佳后行直接切开导管取石,患者无复发现象;患者于治疗后肿胀,疼痛症状有明显缓解,术后均无严重并发症。治疗前后两组VAS评分组内比较差异显著。结论:中西医结合治疗慢性阻塞性涎腺炎具有明显效果,患者疼痛减轻显著,复发率低,提高了慢性阻塞性涎腺患者治愈水平,值得临床推广。Objective:To study the clinical effect of integrated traditional Chinese and western medicine in the treatment of chronic obstructive Salary gland inflammation.Method:Selected 52 cases of chronic obstructive Salary gland inflammation patients from 2004 to 2010 were randomly divided into western medicine group(WM) and combine traditional Chinese (CTC)with each 26 cases.WM group were treated with endoscopic intraductal Salary stone, whereas CTC group were treated on the basis of WM group therapy plus traditional Chinese medicine dialectical therapy.Result:WM group had the successful rate of 21 cases(80.8%), relapses 3 cases(ll.5%), 1 routine remove glands which was obviously lower than'CTC group success 24 patients(92.3%).without reappear ones.There were no difference in VAS before experiments, however there are significant differences between two groups before 6 months after curing, and CTC group has a better result in VAS than WM did.Conclusion:Combining traditional Chinese and western medicine treatment treatin~ chronic obstructive Salary gland inflammation has an obvious effect, it worth to be used in clinical widely.

关 键 词:慢性阻塞性涎腺炎 中西医结合 

分 类 号:R259[医药卫生—中西医结合]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象